ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Guerbet Sa

Guerbet Sa (0ELV)

27.775
0.00
(0.00%)
Closed January 06 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
27.775
Bid
27.10
Ask
28.45
Volume
3
0.00 Day's Range 0.00
27.775 52 Week Range 27.775
Market Cap
Previous Close
27.775
Open
-
Last Trade
3
@
28.3
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
283
Shares Outstanding
12,641,000
Dividend Yield
-
PE Ratio
14.88
Earnings Per Share (EPS)
1.89
Revenue
799.96M
Net Profit
23.87M

About Guerbet Sa

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
Headquarters
Villepinte, Seine-saint-denis, Fra
Founded
1990
Guerbet Sa is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker 0ELV. The last closing price for Guerbet was 27.78 €. Over the last year, Guerbet shares have traded in a share price range of 27.775 € to 27.775 €.

Guerbet currently has 12,641,000 shares outstanding. The market capitalization of Guerbet is 351.10 € million. Guerbet has a price to earnings ratio (PE ratio) of 14.88.

0ELV Latest News

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30...

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM).

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM). Guerbet annonce le...

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31...

GUERBET : Calendrier financier de l'exercice 2025

GUERBET : Calendrier financier de l'exercice 2025 Calendrier financier de l’exercice 2025 Villepinte, le 31 octobre 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de...

GUERBET : Financial agenda for 2025

GUERBET : Financial agenda for 2025 Financial agenda for 2025 Villepinte, 31 October 2024: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is...

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au...

GUERBET : Revenue at September 30, 2024.

GUERBET : Revenue at September 30, 2024. Revenue at September 30, 2024 Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER1                    In the third quarter, momentum...

GUERBET : Chiffre d’affaires au 30 septembre 2024.

GUERBET : Chiffre d’affaires au 30 septembre 2024. Chiffre d’affaires au 30 septembre 2024 Maintien de la dynamique de croissance Chiffre d’affaires à 9 mois : 620,5 M€, en hausse de 9,6% à TCC1...

GUERBET : Mise à disposition du rapport financier semestriel 2024

GUERBET : Mise à disposition du rapport financier semestriel 2024   Mise à disposition du rapport financier semestriel 2024   Mise à disposition du Rapport Financier semestriel 2024 Villepinte, le...

GUERBET : Résultats semestriels 2024.

GUERBET : Résultats semestriels 2024. Résultats semestriels 2024 Activité très dynamique Chiffre d’affaires du 1er semestre : 419,2 M€, en hausse de 11,8% à TCC1                    Une...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10027.77527.77527.775227.775DE
40027.77527.77527.7758427.775DE
120027.77527.77527.77528327.775DE
260027.77527.77527.77520327.775DE
520027.77527.77527.77533327.775DE
1560027.77527.77527.77581727.775DE
260-14.375-34.104389086642.15441672327.96304612DE

0ELV - Frequently Asked Questions (FAQ)

What is the current Guerbet share price?
The current share price of Guerbet is 27.775 €
How many Guerbet shares are in issue?
Guerbet has 12,641,000 shares in issue
What is the market cap of Guerbet?
The market capitalisation of Guerbet is EUR 351.1M
What is the 1 year trading range for Guerbet share price?
Guerbet has traded in the range of 27.775 € to 27.775 € during the past year
What is the PE ratio of Guerbet?
The price to earnings ratio of Guerbet is 14.88
What is the cash to sales ratio of Guerbet?
The cash to sales ratio of Guerbet is 0.44
What is the reporting currency for Guerbet?
Guerbet reports financial results in EUR
What is the latest annual turnover for Guerbet?
The latest annual turnover of Guerbet is EUR 799.96M
What is the latest annual profit for Guerbet?
The latest annual profit of Guerbet is EUR 23.87M
What is the registered address of Guerbet?
The registered address for Guerbet is 15 RUE DES VANESSES, VILLEPINTE, SEINE-SAINT-DENIS, 93420
What is the Guerbet website address?
The website address for Guerbet is www.guerbet.com
Which industry sector does Guerbet operate in?
Guerbet operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
3.25p
(103.13%)
12.18M
BORBorders & Southern Petroleum Plc
3.64p
(51.04%)
23.81M
NEONeo Energy Metals Plc
0.95p
(22.58%)
37.84M
GNIPGenip Plc
32.00p
(20.75%)
192.82k
ZIOCZanaga Iron Ore Company Limited
10.50p
(19.86%)
2.84M
DGIDg Innovate Plc
0.02p
(-20.00%)
298.54M
SNGSynairgen Plc
2.10p
(-19.39%)
1.67M
VRSVersarien Plc
0.03p
(-18.92%)
103.72M
QEDQuadrise Plc
5.90p
(-17.83%)
17.66M
ZENZenith Energy Ltd.
4.90p
(-16.24%)
1.48M
SYMESupply@me Capital Plc
0.0042p
(12.00%)
1.19B
MSMNMosman Oil And Gas Limited
0.035p
(12.90%)
654.48M
TRPTower Resources Plc
0.0395p
(0.00%)
570.56M
CPXCap-xx Limited
0.1775p
(-2.74%)
379.2M
NTVONativo Resources Plc
0.0019p
(-5.00%)
312.89M

Discussion

View Full Feed
Halkid Halkid 1 minute ago
Another wonderful $18 sell at the very end of day , please explain that one
BLFR
TheHound TheHound 2 minutes ago
An iHub chart glitch?
XRPUSD
peafunke peafunke 2 minutes ago
I hear ya lambo.  I'm still here.  Not sure why I'd leave at this point.  There is some hope but it's slowly dwindling.  

Vume summer 2024.  Vume 'end of year' [2024]. Vume 2025 and beyond.  And maybe a smart city or two.  
TPTW
Invest-in-America Invest-in-America 2 minutes ago
FUBO: $10 in less that 15-minutes --- and $20 by end of the Post-M today. No ' Mickey Mouse ' company here, Peeps --- no Disney pun intended. (See ya-all tomorrow, Homeboys!!)
FUBO
Iceman Iceman 2 minutes ago
New all time high today, $51.66
Kona and Jack got the burger.
All time closing high of $51.07!!! That is huge!
Should be mid $50.s for next resistance.

As we can all attest to, this climb is very fast for a nyse stock, not that ionq doesn't deserve it in a hot sec
IONQ
36Knuckle 36Knuckle 2 minutes ago
sentence structure is so important when trying to get a thought across...agreed?
SFLM
0210 0210 3 minutes ago
93m shs traded = 50m buys + 8m(?) vs. 35m sells: https://ih.advfn.com/stock-market/AMEX/aeon-biopharma-AEON/trades
AEON
K-Pax K-Pax 3 minutes ago
$XTIA +100%
XTIA
rbb rbb 4 minutes ago
added twice also,,, wasn't going to but everything is lining up here... volume will come this week - $FDCT
FDCT
k9narc k9narc 5 minutes ago
I've had that cold since Xmas eve.

Thanks.
RNsidersbuying RNsidersbuying 5 minutes ago
SLRN 2.85 - getting clobbered in afterhours on what I view as a favorable report?

The Company previously announced it held an end of Phase 2 meeting with the United States Food and Drug Administration and gained alignment on the proposed LONGITUDE-1 and LONGITUDE-2 Phase 3 trial desig
jgsnys jgsnys 5 minutes ago
Wow! That is so simple. I certainly could not have thought of it. In fact, it is so simple
they should call you "Simple Robert" instead of "Running Robert". As you say, "It is
more of an awareness thing."
ELTP
RunninRobert RunninRobert 5 minutes ago
The unlikely chance that RFK jr, gets confirmed and is able to make any changes to ADHD meds, I believe after he doesnt get confirmed we head back to .70/.80
ELTP
Deportes Deportes 6 minutes ago
Docsetc, ignore the moron I blow. 
ENZC
Newc Newc 6 minutes ago
Nice volume today with recent filings I would have bought more if I saw them. Just caught up on reading.

I only have a small position. I think this can go one of many ways and I see potential. IMO I have some hope and patience.
CAPC
WebSlinger WebSlinger 6 minutes ago
Motley Fool: 1 Nvidia-Backed Artificial Intelligence (AI) Stock to Buy Hand Over Fist in 2025 (Hint: It's Not SoundHound AI)
Jan 6, 2025

Key Points

- Nebius is an artificial-intelligence infrastructure company based in Amsterdam.
- It was divested from Rus
NBIS
WorstLuck WorstLuck 6 minutes ago
That's one of the reasons I think someone will carry the torch for ENTA in peds (i.e. a partner) most likely, but it is going to be back weighted big time (i.e. not much up front) without good adult HR data to provide the adult market as a base and the additional confidence that would provide for pe
ENTA
konshe konshe 6 minutes ago
More buyers coming in ,looks like 0.0005 will be gone Tomorrow. Go CBDL
CBDL
Joe99999! Joe99999! 6 minutes ago
With IKBR back on trading Iqst. We can fly to a new high very soon. In Iqst, I, We always TRUST. Hell yeah!!!!
IQST
RNsidersbuying RNsidersbuying 6 minutes ago
SLRN 2.85 - getting clobbered in afterhours on what I view as a favorable report?

The Company previously announced it held an end of Phase 2 meeting with the United States Food and Drug Administration and gained alignment on the proposed LONGITUDE-1 and LONGITUDE-2 Phase 3 trial desig
investingnotgambling investingnotgambling 7 minutes ago
Nope. Wasn’t me. I was considering buying them at .019…didn’t act on it.

🇺🇸😎🦅
ZHUD
kgromax kgromax 7 minutes ago
Yep it’s low quality PRs.

Pump, pump, pump !

It’s the 40th Cytodyn pump.

And every time it falls lower and lower.

MWA AH AH AH AH
CYDY
peafunke peafunke 7 minutes ago
Funny thing is Mx has allegations with zero 'evidence' where as the evidence pointing to fraud is constant and available on this board outing Mx over the past several years imo. 
TPTW
getmoreshares getmoreshares 7 minutes ago
$1 vol
HOMU
flipper44 flipper44 7 minutes ago
No trauma here. I simply don’t like bullies.🙂
NWBO

Your Recent History

Delayed Upgrade Clock